The role of intraamniotic inflammation in threatened midtrimester miscarriage

Am J Obstet Gynecol. 2022 Dec;227(6):895.e1-895.e13. doi: 10.1016/j.ajog.2022.07.007. Epub 2022 Jul 16.

Abstract

Background: The assessment and management of patients with threatened midtrimester miscarriage is a clinical challenge because the etiology of this condition is poorly understood.

Objective: This study aimed to examine the frequency of intraamniotic infection or inflammation and the effect of antibiotics in patients presenting with regular uterine contractions and intact membranes before 20 weeks of gestation.

Study design: This retrospective study comprised patients who met the following criteria: (1) singleton gestation, (2) gestational age before 20 weeks, (3) the presence of regular uterine contractions confirmed by a tocodynamometer (8 or more contractions in 60 minutes), (4) intact amniotic membranes, and (5) transabdominal amniocentesis performed for the evaluation of the microbiologic and inflammatory status of the amniotic cavity. Samples of amniotic fluid were cultured for aerobic and anaerobic bacteria and genital mycoplasmas, and polymerase chain reaction was performed to detect Ureaplasma species. Amniotic fluid was tested for white blood cell counts and matrix metalloproteinase-8 concentrations to diagnose intraamniotic inflammation. Patients with intraamniotic inflammation, or intraamniotic infection, were treated with antibiotics (a combination of ceftriaxone, clarithromycin, and metronidazole). Treatment success was defined as the resolution of intraamniotic infection/inflammation at the follow-up amniocentesis or delivery after 34 weeks of gestation.

Results: 1) Intraamniotic inflammation was present in 88% (15/17) of patients, whereas infection was detectable in only 2 cases; 2) objective evidence of resolution of intraamniotic inflammation after antibiotic treatment was demonstrated in 100% (4/4) of patients who underwent a follow-up amniocentesis; 3) 30% (5/15) of women receiving antibiotics delivered after 34 weeks of gestation (3 of the 5 patients had a negative follow-up amniocentesis, and 2 of the women were without a follow-up amniocentesis); 4) the overall treatment success of antibiotics was 40% (6/15; 4 cases of objective evidence of resolution of intra-amniotic inflammation and 5 cases of delivery after 34 weeks of gestation).

Conclusion: The prevalence of intraamniotic inflammation in patients who presented with a threatened midtrimester miscarriage was 88% (15/17), and, in most cases, microorganisms could not be detected. Antibiotic treatment, administered to patients with intraamniotic inflammation, was associated with either objective resolution of intraamniotic inflammation or delivery after 34 weeks of gestation in 40% (6/15) of the cases.

Keywords: Ureaplasma urealyticum; amniotic fluid; antibiotics; antimicrobial agents; ceftriaxone; cephalosporins; chorioamnionitis; chorioamniotic membranes; clarithromycin; funisitis; healing; interleukin-6; intraamniotic infection; matrix metalloproteinase-8; membrane rupture; metronidazole; pregnancy; prematurity; resealing of the membranes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortion, Spontaneous* / drug therapy
  • Abortion, Spontaneous* / epidemiology
  • Abortion, Threatened* / drug therapy
  • Amniocentesis / adverse effects
  • Amniotic Fluid / microbiology
  • Anti-Bacterial Agents / therapeutic use
  • Chorioamnionitis* / diagnosis
  • Chorioamnionitis* / drug therapy
  • Chorioamnionitis* / epidemiology
  • Female
  • Humans
  • Inflammation / complications
  • Pregnancy
  • Pregnancy Trimester, Second
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents